You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Annexin A5 scintigraphy

Showing 1 - 25 of 872
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Groningen (ANXV, Placebo)

Completed
  • Healthy
  • ANXV
  • Placebo
  • Groningen, Netherlands
    QPS Netherlands B.V.
May 12, 2022

Sepsis Trial in Nanjing (SY-005, Placebo)

Recruiting
  • Sepsis
  • Nanjing, Jiangsu, China
    Zhongda Hospital，Affiliated to Southeast University
Feb 27, 2022

Coronavirus Infection, Sepsis Trial in London (recombinant human annexin A5, Placebo)

Recruiting
  • Coronavirus Infection
  • Sepsis
  • recombinant human annexin A5
  • Placebo
  • London, Ontario, Canada
    London Health Sciences Centre
Apr 23, 2021

Bone Cancer, Articular Disease, Infectious Disease Trial in Sherbrooke (18F-sodium fluoride)

Recruiting
  • Bone Cancer
  • +2 more
  • 18F-sodium fluoride
  • Sherbrooke, Quebec, Canada
  • +1 more
Jul 18, 2022

Neuroblastoma Trial in Montréal, Sherbrooke (Radiopharmaceutical 68Ga-DOTATATE)

Recruiting
  • Neuroblastoma
  • Radiopharmaceutical 68Ga-DOTATATE
  • Montréal, Quebec, Canada
  • +2 more
Jan 3, 2023

Gastroesophageal Reflux Disease Trial in Merthyr Tydfil (Z0063, Gaviscon)

Completed
  • Gastroesophageal Reflux Disease
  • Merthyr Tydfil, United Kingdom
    Investigational site 826001
Apr 21, 2022

Carotid Atherosclerosis, Atherosclerotic Plaque Trial (99mTc-Annexin-V-128 uptake on scintigraphy)

Withdrawn
  • Carotid Atherosclerosis
  • Atherosclerotic Plaque
  • 99mTc-Annexin-V-128 uptake on scintigraphy
  • (no location specified)
Oct 15, 2021

Sepsis Trial in Nanjing (SY-005)

Completed
  • Sepsis
  • Nanjing, Jiangsu, China
    Jiangsu Province Hospital
May 31, 2021

Systemic Amyloidosis Trial in Knoxville (99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.,

Recruiting
  • Systemic Amyloidosis
  • 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
  • 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m.
  • Knoxville, Tennessee
    University of Tennessee Graduate School of Medicine
Jul 10, 2023

Retinal Vein Occlusion Trial in Groningen (Annexin A5)

Recruiting
  • Retinal Vein Occlusion
  • Annexin A5
  • Groningen, Netherlands
    UMCG
Nov 11, 2021

Endocarditis, Thrombosis Trial in Paris (99mTc-Annexin V-128 SPECT)

Terminated
  • Endocarditis
  • Thrombosis
  • 99mTc-Annexin V-128 SPECT
  • Paris, France
    Bichat Hospital
Aug 25, 2021

Malignant Solid Tumor, Ovarian Low Grade Serous Adenocarcinoma, Pancreatic Carcinoma Trial (Binimetinib, Biopsy, Biospecimen

Not yet recruiting
  • Malignant Solid Neoplasm
  • +4 more
  • (no location specified)
Nov 8, 2022

Breast Carcinoma, Colorectal Carcinoma Trial in Duarte (procedure, drug, radiation)

Not yet recruiting
  • Breast Carcinoma
  • Colorectal Carcinoma
  • Biopsy
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Nov 8, 2023

An Imaging Study of FCH-PET-CT in Prostate Cancer andBRCA Gene

Recruiting
  • Prostate Cancer
  • +2 more
  • MRI pelvis or CT imaging
  • +2 more
  • London, Sutton, Surrey, United Kingdom
    Cancer Genetics Unit, Royal Marsden Hospital
Mar 30, 2022

Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial

Not yet recruiting
  • Recurrent Biliary Tract Carcinoma
  • +13 more
  • (no location specified)
Nov 8, 2022

GCF Annexin-A1, Carbonic Anhydrase-1, and Elongation Factor-1

Completed
  • Periodontitis
  • Periodontal Inflammation
  • Peirodontal clinical measurements and gingival crevicular fluid sampling
  • İzmir, Turkey
    Dokuz Eylul University, Faculty of Dentistry, Department of Peri
Jan 10, 2023

Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)

Not yet recruiting
  • Localized Osteosarcoma
  • +3 more
  • Bone Scan
  • +7 more
  • (no location specified)
Jan 18, 2023

Coagulation Status of Pregnant Peripartum Period Using Device

Recruiting
  • Coagulation and Hemorrhagic Disorders
  • Coagulation test on device ClotPro
  • Brno, Czechia
    University Hospital Brno
Jul 5, 2023

Thyroid Cancer, Intermediate Risk Trial in France (Systematic RAI-treatment, Decision of RAI-treatment guided by a

Recruiting
  • Thyroid Cancer
  • Intermediate Risk
  • Systematic RAI-treatment
  • Decision of RAI-treatment guided by a post-operative assessment
  • Angers, France
  • +26 more
Jul 26, 2022

Xerostomia Following Radiotherapy Trial in Ljubljana (allogeneic mesenchymal stromal stem cells)

Not yet recruiting
  • Xerostomia Following Radiotherapy
  • allogeneic mesenchymal stromal stem cells
  • Ljubljana, Slovenia
  • +3 more
Aug 22, 2023

Rheumatic Disease, Tumors, Parathyroid Diseases Trial in Orléans (Scintigraphy)

Completed
  • Rheumatic Disease
  • +8 more
  • Scintigraphy
  • Orléans, France
    CHR d'Orleans
Nov 2, 2021

Coronary Stenosis, Diabetic Trial in Bron (dual-energy dual-layer spectral scanner, Stress protocol with adenosin during

Not yet recruiting
  • Coronary Stenosis
  • Diabetic
  • dual-energy dual-layer spectral scanner
  • Stress protocol with adenosin during dual-energy dual-layer spectral scanner
  • Bron, France
    Hospices Civils de Lyon
Jul 20, 2022

Breast Cancer Female, Breast Cancer Recurrent Trial in Drammen (18F-FDG PET/CT)

Recruiting
  • Breast Cancer Female
  • Breast Cancer Recurrent
  • 18F-FDG PET/CT
  • Drammen, Norway
    Drammen Hospital - Vestre Viken HF
Feb 17, 2023

Liver Metastases, Liver Cancer, Liver Tumors Trial in Warsaw (PVE, LVD, ALPPS)

Not yet recruiting
  • Liver Metastases
  • +3 more
  • PVE
  • +2 more
  • Warsaw, Mazowieckie, Poland
    Second Department of Clinical Radiology
Sep 17, 2023

Pulmonary Embolism, Pulmonary Embolus/Emboli Trial in Denmark (Point-of-care-ultrasound examination)

Recruiting
  • Pulmonary Embolism
  • Pulmonary Embolus/Emboli
  • Point-of-care-ultrasound examination
  • Esbjerg, Denmark
  • +4 more
May 30, 2022